ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2720

Genome-Wide Association Study of Clinical Phenotypes in Psoriatic Arthritis

Juan D. Cañete1, Jose A Pinto-Tasende2, Jordi Gratacós3, Rubén Queiro4, Carlos Alberto Montilla Morales5, Juan Carlos Torre-Alonso6, Jose Javier Perez Venegas7, Antonio Fernandez-Nebro8, Santiago Muñoz9, Carlos Gonzalez10, Daniel Roig11, Pedro Zarco12, Alba Erra13, Jesus Rodriguez14, Santos Castañeda15, Esteban Rubio-Romero16, Georgina Salvador17, Cesar Diaz-Torné18, Ricardo Blanco19, Alfredo Willisch20, Jose Antonio Mosquera21, Paloma Vela22, Jesús Tornero23, Simon Sanchez Fernandez24, Hector Corominas25, Julio Ramírez26, Maria López-Lasanta27, Mireia López28, Raül Tortosa29, Antonio Julià29 and Sara Marsal30, 1Rheumatology Department, Hospital Clínic de Barcelona, Barcelona, Spain, 2Rheumatology Division, INIBIC-Complejo Hospitalario Universitario A Coruña (CHUAC), A Coruna, Spain, 3Rheumatology, Hospital de Sabadell, Sabadell, Spain, 4H Central de Asturias, Oviedo, Spain, 5Rheumatology, HOSPITAL CLÍNICO UNIVERSITARIO DE SALAMANCA, Salamanca, Spain, 6H Monte Naranco, Oviedo, Spain, 7Rheumatology, Hospital de Jerez de la Frontera, Jerez de la Frontera, Spain, 8Rheumatology, Hospital Universitario Carlos Haya, Malaga, Spain, 9Rheumatology, Hospital Infanta Sofia, Madrid, Spain, 10Servicio de Reumatología, Hospital Universitario Gregorio Marañón, MD, PhD, Madrid, Spain, 11Rheumatology Service, Hospital Universitari de Bellvitge, Hospitalet de Llobregat- Barcelona, Spain, 12H Fundación Alcorcón, Alcorcón, Spain, 13CapiCAT group (Nailfold Capillaroscopy group from the Catalan Society for Rheumatology)., Catalonia, Spain, 14Rheumatology, Hospital Universitari de Bellvitge, Barcelona, Spain, 15Rheumatology, Hospital de la Princesa, IIS-IP, Madrid, Spain, 16Rheumatology, Rheumatology, Seville, Spain, 17Rheumatology Unit., Hospital Mutua de Terrassa. Barcelona, Barcelona, Spain, 18Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 19Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 20Complexo Hospitalario de Ourense, Ourense, Spain, 21Servicio de Reumatología, Complejo Hospitalario Hospital Provincial de Pontevedra, Pontevedra, Spain, 22Dpt. Rheumatology, Hospital General Universitario Alicante, Alicante, Spain, 23Rheumatology Department, Hospital Universitario Guadalajara, Guadalajara, Spain, 24Rheumatology Department, Hospital General La Mancha Centro, Ciudad Real, Spain, 25Rheumatology, Hospital Moises Broggi, Barcelona, Spain, 26Rheumatology, Hospital Clínic, Barcelona, Spain, 27Vall d'Hebron Hospital Research Institute, Barcelona, Spain, 28Servicio de Reumatología, Hospital Universitario Vall d´Hebron, Barcelona, Spain, 29Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain, 30Rheumatology Research Unit, Vall d'Hebron Hospital, Barcelona, Spain

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Genetic architecture, GWAS, phenotypes and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Genome-wide association studies (GWAS) in patients and healthy controls have allowed the identification of multiple variants associated with disease risk in Psoriatic Arthritis (PsA). To date, however, there has been no GWAS for PsA phenotypes. The main objective of this study was to identify new genetic variation associated with clinical phenotypes in PsA.

Methods:  A total of n=835 patients diagnosed with PsA using CASPAR criteria were recruited for the discovery stage. In each patient >600,000 single nucleotide polymorphisms (SNPs) were genotyped. All patients were Caucasian and of Spanish origin. GWAS were performed for clinical and biological phenotypes associated with joint disease, as well as skin disease related phenotypes. After allelic association analysis, those SNPs with highest level of significance were analyzed in an independent cohort of n=414 PsA patients.

Results: In the GWAS stage, several genomic regions showing high evidence of association with different PsA phenotypes (P<5e-6) were identified. These included association with axial disease pattern, peripheral disease pattern, bone proliferation, degree of radiological sacroileitis and the presence of syndesmophytes. Also, GWAS on cutaneous variables identified two regions associated with nail disease and skin disease severity. Using the replication cohort, the association between one locus and peripheral pattern of disease, and two loci associated with axial pattern were nominally validated.

Conclusion: To our knowledge, this is the GWAS of clinical phenotypes in PsA. New candidate loci associated with axial and peripheral disease have been identified.


Disclosure: J. D. Cañete, None; J. A. Pinto-Tasende, None; J. Gratacós, None; R. Queiro, None; C. A. Montilla Morales, None; J. C. Torre-Alonso, None; J. J. Perez Venegas, None; A. Fernandez-Nebro, None; S. Muñoz, None; C. Gonzalez, None; D. Roig, None; P. Zarco, None; A. Erra, None; J. Rodriguez, None; S. Castañeda, None; E. Rubio-Romero, None; G. Salvador, None; C. Diaz-Torné, None; R. Blanco, None; A. Willisch, None; J. A. Mosquera, None; P. Vela, None; J. Tornero, None; S. Sanchez Fernandez, None; H. Corominas, None; J. Ramírez, None; M. López-Lasanta, None; M. López, None; R. Tortosa, None; A. Julià, None; S. Marsal, None.

To cite this abstract in AMA style:

Cañete JD, Pinto-Tasende JA, Gratacós J, Queiro R, Montilla Morales CA, Torre-Alonso JC, Perez Venegas JJ, Fernandez-Nebro A, Muñoz S, Gonzalez C, Roig D, Zarco P, Erra A, Rodriguez J, Castañeda S, Rubio-Romero E, Salvador G, Diaz-Torné C, Blanco R, Willisch A, Mosquera JA, Vela P, Tornero J, Sanchez Fernandez S, Corominas H, Ramírez J, López-Lasanta M, López M, Tortosa R, Julià A, Marsal S. Genome-Wide Association Study of Clinical Phenotypes in Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/genome-wide-association-study-of-clinical-phenotypes-in-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genome-wide-association-study-of-clinical-phenotypes-in-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology